Deacetylprotoveratrine A
Internal ID | 0781dc53-f666-401d-bcc0-093491440489 |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal alkaloids > Cerveratrum-type alkaloids |
IUPAC Name | [(1S,2S,6S,9S,11R,12R,13S,14S,15S,16S,17R,18R,19S,22S,23S,25R)-17-acetyloxy-10,12,14,16,23-pentahydroxy-6,10,19-trimethyl-13-[(2R)-2-methylbutanoyl]oxy-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] (2S)-2-hydroxy-2-methylbutanoate |
SMILES (Canonical) | CCC(C)C(=O)OC1C(C2C(CN3CC(CCC3C2(C)O)C)C4C1(C5C(C(C6C7(C5(C4)OC6(C(CC7)OC(=O)C(C)(CC)O)O)C)OC(=O)C)O)O)O |
SMILES (Isomeric) | CC[C@@H](C)C(=O)O[C@H]1[C@@H]([C@H]2[C@@H](CN3C[C@H](CC[C@H]3C2(C)O)C)[C@H]4[C@@]1([C@@H]5[C@@H]([C@@H]([C@H]6[C@]7([C@]5(C4)O[C@@]6([C@H](CC7)OC(=O)[C@](C)(CC)O)O)C)OC(=O)C)O)O)O |
InChI | InChI=1S/C39H61NO13/c1-9-19(4)32(44)52-31-26(42)25-21(17-40-16-18(3)11-12-23(40)36(25,8)47)22-15-37-29(38(22,31)48)27(43)28(50-20(5)41)30-34(37,6)14-13-24(39(30,49)53-37)51-33(45)35(7,46)10-2/h18-19,21-31,42-43,46-49H,9-17H2,1-8H3/t18-,19+,21-,22-,23-,24-,25+,26+,27+,28-,29+,30-,31-,34-,35-,36?,37+,38-,39+/m0/s1 |
InChI Key | TWZQQKSYGPDWKZ-BRNBNTERSA-N |
Popularity | 0 references in papers |
Molecular Formula | C39H61NO13 |
Molecular Weight | 751.90 g/mol |
Exact Mass | 751.41429100 g/mol |
Topological Polar Surface Area (TPSA) | 213.00 Ų |
XlogP | 1.60 |
Atomic LogP (AlogP) | 1.04 |
H-Bond Acceptor | 14 |
H-Bond Donor | 6 |
Rotatable Bonds | 7 |
There are no found synonyms. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.6715 | 67.15% |
Caco-2 | - | 0.8634 | 86.34% |
Blood Brain Barrier | + | 0.7250 | 72.50% |
Human oral bioavailability | - | 0.6714 | 67.14% |
Subcellular localzation | Lysosomes | 0.6149 | 61.49% |
OATP2B1 inhibitior | - | 0.7379 | 73.79% |
OATP1B1 inhibitior | + | 0.9305 | 93.05% |
OATP1B3 inhibitior | + | 0.9480 | 94.80% |
MATE1 inhibitior | - | 0.9000 | 90.00% |
OCT2 inhibitior | - | 0.8000 | 80.00% |
BSEP inhibitior | + | 0.6554 | 65.54% |
P-glycoprotein inhibitior | + | 0.7569 | 75.69% |
P-glycoprotein substrate | + | 0.7016 | 70.16% |
CYP3A4 substrate | + | 0.7439 | 74.39% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.7867 | 78.67% |
CYP3A4 inhibition | - | 0.8309 | 83.09% |
CYP2C9 inhibition | - | 0.9078 | 90.78% |
CYP2C19 inhibition | - | 0.9025 | 90.25% |
CYP2D6 inhibition | - | 0.9308 | 93.08% |
CYP1A2 inhibition | - | 0.9425 | 94.25% |
CYP2C8 inhibition | + | 0.7364 | 73.64% |
CYP inhibitory promiscuity | - | 0.9613 | 96.13% |
UGT catelyzed | - | 0.6000 | 60.00% |
Carcinogenicity (binary) | - | 1.0000 | 100.00% |
Carcinogenicity (trinary) | Non-required | 0.5302 | 53.02% |
Eye corrosion | - | 0.9891 | 98.91% |
Eye irritation | - | 0.9118 | 91.18% |
Skin irritation | - | 0.7598 | 75.98% |
Skin corrosion | - | 0.9349 | 93.49% |
Ames mutagenesis | - | 0.6274 | 62.74% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.4602 | 46.02% |
Micronuclear | + | 0.5500 | 55.00% |
Hepatotoxicity | + | 0.5666 | 56.66% |
skin sensitisation | - | 0.8817 | 88.17% |
Respiratory toxicity | + | 0.7111 | 71.11% |
Reproductive toxicity | + | 0.9000 | 90.00% |
Mitochondrial toxicity | + | 0.9750 | 97.50% |
Nephrotoxicity | + | 0.5177 | 51.77% |
Acute Oral Toxicity (c) | I | 0.8149 | 81.49% |
Estrogen receptor binding | + | 0.6941 | 69.41% |
Androgen receptor binding | + | 0.7601 | 76.01% |
Thyroid receptor binding | - | 0.5803 | 58.03% |
Glucocorticoid receptor binding | + | 0.7265 | 72.65% |
Aromatase binding | + | 0.6636 | 66.36% |
PPAR gamma | + | 0.7353 | 73.53% |
Honey bee toxicity | - | 0.6679 | 66.79% |
Biodegradation | - | 0.7750 | 77.50% |
Crustacea aquatic toxicity | + | 0.5800 | 58.00% |
Fish aquatic toxicity | + | 0.7302 | 73.02% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.95% | 97.25% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.25% | 96.09% |
CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 98.02% | 96.77% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 97.82% | 85.14% |
CHEMBL1914 | P06276 | Butyrylcholinesterase | 97.78% | 95.00% |
CHEMBL4681 | P42330 | Aldo-keto-reductase family 1 member C3 | 97.21% | 89.05% |
CHEMBL2581 | P07339 | Cathepsin D | 96.16% | 98.95% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 92.21% | 96.47% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 91.97% | 82.69% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 91.96% | 97.14% |
CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 90.77% | 95.36% |
CHEMBL3922 | P50579 | Methionine aminopeptidase 2 | 90.74% | 97.28% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 90.09% | 95.89% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 89.96% | 86.33% |
CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 89.61% | 82.50% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 89.50% | 100.00% |
CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 89.22% | 100.00% |
CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 89.21% | 96.61% |
CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 88.63% | 89.50% |
CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 88.47% | 87.16% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 87.70% | 93.56% |
CHEMBL3746 | P80365 | 11-beta-hydroxysteroid dehydrogenase 2 | 87.31% | 94.78% |
CHEMBL2996 | Q05655 | Protein kinase C delta | 87.22% | 97.79% |
CHEMBL5255 | O00206 | Toll-like receptor 4 | 86.87% | 92.50% |
CHEMBL299 | P17252 | Protein kinase C alpha | 86.79% | 98.03% |
CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 86.76% | 98.75% |
CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 86.53% | 99.17% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 85.12% | 95.89% |
CHEMBL2094135 | Q96BI3 | Gamma-secretase | 85.06% | 98.05% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 84.73% | 100.00% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 84.64% | 96.90% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 84.34% | 97.09% |
CHEMBL4051 | P13569 | Cystic fibrosis transmembrane conductance regulator | 84.14% | 95.71% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 84.04% | 89.00% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.78% | 100.00% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 83.22% | 94.45% |
CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 82.78% | 91.03% |
CHEMBL204 | P00734 | Thrombin | 82.74% | 96.01% |
CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 81.98% | 94.00% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 81.37% | 91.11% |
CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 81.22% | 93.04% |
CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 81.20% | 99.00% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 81.17% | 99.23% |
CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 81.14% | 95.71% |
CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 80.68% | 97.29% |
CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 80.36% | 97.50% |
CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 80.29% | 95.17% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 80.16% | 93.00% |
CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 80.14% | 92.62% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Veratrum nigrum |
PubChem | 102093842 |
NPASS | NPC47762 |
LOTUS | LTS0053746 |
wikiData | Q104395511 |